Hep C Discussion Forum

Members Login
Username 
 
Password 
    Remember Me  
Chatbox
Please log in to join the chat!
Post Info TOPIC: Showing Interferon the Door


Guru

Status: Offline
Posts: 1724
Date:
RE: Showing Interferon the Door
Permalink  
 


OldenSlow wrote:

I registered with CCO earlier this year and have watched a few presentations. They don't bombard you with emails or anything like that. They send alerts about upcoming presentations pertaining to your areas of interest and that's about it. User friendly IMO.


Wayne is the one who turned me onto this web site when he posted a link months ago.  I'm actually surprised that they are allowing the public to view CME presentations as most are exclusively for health care professionals (you have to give your licensing info) and most are quite expensive to attend.   As far as I can tell this will be a live webcast directly from the AASLD conference in Boston.  Very cool.  

Excellent resource, Wayne.



__________________

Diagnosed in 2011, Incivek triple in 2011, tx discontinued, Genotype 1a, CT, VL 7mill, cirrhosis dx in 2012, age 67, waiting for new DAAs.



Senior Member

Status: Offline
Posts: 380
Date:
Permalink  
 

I registered with CCO earlier this year and have watched a few presentations. They don't bombard you with emails or anything like that. They send alerts about upcoming presentations pertaining to your areas of interest and that's about it. User friendly IMO.



__________________

66 y/o male - Geno 1b - F4 cirrhotic dx 2001 - 16 wk treatment w/ Sovaldi/Olysio/Riba - Und @ EOT+24 SVR

 

LC


Senior Member

Status: Offline
Posts: 473
Date:
Permalink  
 

Thank God for those of you who are intellectually curious because the rest of us can just cheat off your notes.

__________________

Genotype 1a, VL 1,151,923.  51 years old.  Started treatment on AbbVie TOPAZ II clinical trial Oct 10, 2014!  Undetected at weeks 2 and 4! 



Guru

Status: Offline
Posts: 915
Date:
Permalink  
 

Thanks isiscat.   I will join today and post how it went!  RC 



__________________

 M-68, 3 Treatments)( SOF-RIBA 2014)(SOF-RIBA-PEG 2016)(HCC 2016) (LIVER TRANSPLANT 8-2017)(VOSEVI-RIBA 2017)   SVR-12. 3-13-18   



Guru

Status: Offline
Posts: 1724
Date:
Permalink  
 

So, after you sign up they send you an email confirmation and all you have to do is log in at the given time.  Note that it starts at 7pm EST on Sunday so if you are in a different time zone you will need to adjust the time accordingly.  I feel a little like a gate crasher, but hey, nobody stopped me.  I am assuming they will send a link to the webcast before the event with a pass code.

Here is what you will receive after you register:

CCO_RegOnline_Header_HEP.png
YOUR CONFIRMATION 

All-Oral Therapy for HCV: A New Era Begins

On behalf of the Postgraduate Institute for Medicine, and Clinical Care Options, we are pleased to confirm your registration for the upcoming event.
           
Date: Sunday, November 9, 2014
Time7:00 PM - 9:00 PM Eastern time Webcast

Need a reminder?
Click here for a Microsoft Outlook "Add to My Calendar" Link.


PROGRAM AGENDA
            

Welcome and Introduction
Program Director: Nezam H. Afdhal, MD, FRCPI

Showing Interferon the Door: HCV Therapy Thats Safe, Easy, and Effective
Jordan J. Feld, MD, MPH

The Patient Perspective on All-Oral Therapy

All-Oral Therapy for Previously Hard-to-Treat Patients
Paul Y. Kwo, MD

Panel Discussion: Fulfilling the Potential of All-Oral Therapy
Moderator: Nezam H. Afdhal, MD
Panel: Jordan J. Feld, MD; Paul Y. Kwo, MD; and Nancy Reau, MD, MPH

Question and Answer Session
Program Director: Nezam H. Afdhal, MD



Complete program information regarding faculty, agenda, and CME credit is available online at:clinicaloptions.com/Era

Questions? Please email registration@clinicaloptions.com




__________________

Diagnosed in 2011, Incivek triple in 2011, tx discontinued, Genotype 1a, CT, VL 7mill, cirrhosis dx in 2012, age 67, waiting for new DAAs.



Guru

Status: Offline
Posts: 1724
Date:
Permalink  
 

Hi RC:

I just registered.  It is a Continuing Medical Education class so the target audience is healthcare professionals (which I am not) but I filled out the registration form honestly and they let me sign up.  You do have to give them your name, address, email address, etc.  



__________________

Diagnosed in 2011, Incivek triple in 2011, tx discontinued, Genotype 1a, CT, VL 7mill, cirrhosis dx in 2012, age 67, waiting for new DAAs.



Guru

Status: Offline
Posts: 915
Date:
Permalink  
 

that will be one web cast I will want to see. I cant wait to see it.  I went to the web site it looks like you need to registure to see it?? anyone know if thats the only way to see it??    Anyone ever done that?   To be able to sit/listen in on a bunch of doctors talking about how to treat  hard to treat patient"s  Thats going to be good   Thanks isiscat2011    RC



__________________

 M-68, 3 Treatments)( SOF-RIBA 2014)(SOF-RIBA-PEG 2016)(HCC 2016) (LIVER TRANSPLANT 8-2017)(VOSEVI-RIBA 2017)   SVR-12. 3-13-18   



Senior Member

Status: Offline
Posts: 479
Date:
Permalink  
 

bout time. I hated that stuff..



__________________

TazKat Genotype 1A null responder x 3 riba & iterferon twice, relapsed from Incivek 2012 with only 12 weeks left to do. stage 4 mild cirrhosis 4/25/2014/ started sovaldi riba & interferon.. finished treatment 7/17/14  results 7/25  cleared..

 

 

LC


Senior Member

Status: Offline
Posts: 473
Date:
Permalink  
 

I like they way they think.

__________________

Genotype 1a, VL 1,151,923.  51 years old.  Started treatment on AbbVie TOPAZ II clinical trial Oct 10, 2014!  Undetected at weeks 2 and 4! 



Guru

Status: Offline
Posts: 1724
Date:
Permalink  
 

The 65th Annual AASLD meeting will be underway soon.  For docs who are unable to attend in person there is webcast option for a 2 hour presentation on HCV tx.  Just thought the agenda might be of interest to us patients as well.  I especially like the presentation about "Showing Interferon the Door."  

http://www.clinicaloptions.com/Hepatitis/Live%20Events/Webcast/All-Oral%20HCV%20Therapy/Tabs/Agenda.aspx

Agenda

Welcome and Introduction
Program Director: Nezam H. Afdhal, MD, FRCPI


Showing Interferon the Door: HCV Therapy Thats Safe, Easy, and Effective
Jordan J. Feld, MD, MPH


The Patient Perspective on All-Oral Therapy


All-Oral Therapy for Previously Hard-to-Treat Patients
Paul Y. Kwo, MD


Panel Discussion: Fulfilling the Potential of All-Oral Therapy
Moderator: Nezam H. Afdhal, MD, FRCPI
Panel: Jordan J. Feld, MD, MPH; Paul Y. Kwo, MD; and Nancy Reau, MD


Question and Answer Session
Program Director: Nezam H. Afdhal, MD, FRCPI

 
Event Date Details
Sunday, November 9, 2014
7:00 PM - 9:00 PM Eastern time Webcast
 
 

 



__________________

Diagnosed in 2011, Incivek triple in 2011, tx discontinued, Genotype 1a, CT, VL 7mill, cirrhosis dx in 2012, age 67, waiting for new DAAs.

Page 1 of 1  sorted by
 
Quick Reply

Please log in to post quick replies.

Legal Disclaimer:

THIS FORUM, IT'S OWNERS, ADMINISTRATORS, MODERATORS AND MEMBERS DO NOT AT ANY TIME GIVE MEDICAL ADVICE AND IN ALL CASES REFER ANYONE HERE TO SEEK APPROPRIATE MEDICAL ADVICE FROM THEIR DOCTOR.